Status:

WITHDRAWN

Triheptanoin Treatment Trial for Patients With Long-chain Fatty Acid Beta-oxidation Defects

Lead Sponsor:

Maria Luz Couce Pico

Collaborating Sponsors:

Fundación Ramón Domínguez

Conditions:

Long-chain Fatty Acid Transport Deficiency

Eligibility:

All Genders

Phase:

PHASE3

Brief Summary

The purpose of this study is to determine if administration Triheptanoin is an effective treatment for defects of the long-chain fatty acid beta-oxidation in young adults or adults. Period of treatmen...

Detailed Description

Triheptanoin treatment, in patients with long-chain fatty acid beta-oxidation defects, could cause not only a great improvement in their quality of life, also could prevent life-threatening signs, red...

Eligibility Criteria

Inclusion

  • All patients with any of the following conditions:
  • Long-chain 3-hydroxyacyl-coenzyme A dehydrogenase deficiency (LCHAD).
  • Very long-chain acyl-coenzyme A dehydrogenase deficiency (VLCAD.)
  • Mitochondrial trifunctional protein (MTP).
  • Carnitine palmitoyltransferase I deficiency (CPT I).
  • Carnitine Palmitoyltransferase II (CPT II).
  • Carnitine-acylcarnitine translocase deficiency (CACT).
  • Positive skin biopsy: patients were deemed to commence the dietary treatment with Triheptanoin after evaluating the individual response in vitro in cultured fibroblasts. This response is based on the measurement of the production of propionyl-CoA, the incubation with fatty acids odd-chain, compared with control group fibroblasts.
  • The informed consent must be signed by the patient or family, in the case of minors.

Exclusion

  • No patient/family collaboration or the application of dietary treatment.
  • No in vitro test response.
  • Do not meet the inclusion criteria.

Key Trial Info

Start Date :

November 1 2009

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

October 1 2011

Estimated Enrollment :

Patients enrolled

Trial Details

Trial ID

NCT02201368

Start Date

November 1 2009

End Date

October 1 2011

Last Update

July 28 2014

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Hospital Clínico Universitario de Santiago

Santiago de Compostela, Spain

Triheptanoin Treatment Trial for Patients With Long-chain Fatty Acid Beta-oxidation Defects | DecenTrialz